CHO-PD-L1 Cells
2 622,00 CAD$*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Renseignements généraux
| Description | Disclaimer: The prices displayed for cell lines are exclusively for academic/not-for-profit customers. For commercial entitites the price is approximately €6,250. CHO-PD-L1 cells are recombinant Chinese hamster ovary (CHO) cells engineered to stably express human programmed death-ligand 1 (PD-L1; CD274/B7-H1), an immune checkpoint ligand that plays a central role in suppression of T-cell-mediated immune responses. PD-L1 is a type I transmembrane protein that interacts primarily with programmed cell death protein 1 (PD-1/CD279) on activated immune cells, leading to inhibition of T-cell proliferation, cytokine production, and cytotoxic activity. Aberrant PD-L1 expression is a common mechanism of immune evasion in multiple solid tumors and hematologic malignancies, making PD-L1-expressing recombinant cell models highly relevant for immuno-oncology research and therapeutic development. CHO-PD-L1 cells are widely used for the development and characterization of immune checkpoint inhibitors, including monoclonal antibodies, bispecific antibodies, fusion proteins, and engineered cell therapies targeting the PD-1/PD-L1 signaling axis. The stable and controlled expression of PD-L1 enables quantitative evaluation of antibody binding affinity, receptor occupancy, blocking activity, internalization, and ligand-receptor interaction kinetics. These cells are also suitable for flow cytometry assay development, reporter bioassays, T-cell activation studies, and high-throughput screening platforms designed to assess checkpoint blockade efficacy or immune synapse formation. Because CHO cells provide a robust and relatively low-background expression system, they are frequently selected for standardized assay generation and biologic quality control applications. |
|---|---|
| Organisme | Chinese hamster |
| Tissu | Ovary |
| Maladie | Chinese hamster ovary, non-neoplastic; genetically engineered for PD-L1 (CD274/B7-H1) surface expression |
| Applications | Antibody screening; PD-L1-targeted immunotherapy development; checkpoint inhibitor research; tumor immune evasion studies; flow cytometry |
Caractéristiques
| Âge | Adult |
|---|---|
| Genre | Female |
| Morphologie | Epithelial-like |
| Type de cellule | Epithelial cells |
| Propriétés de croissance | Adherent/suspension |
Données réglementaires
| Référence | CHO-PD-L1 (Cytion catalog number 305975) |
|---|---|
| Niveau de biosécurité | 1 |
| NCBI_Numéro d'identification fiscale | 10029 |
| Cellosaurus - Numéro d'enregistrement | CVCL_A8X1 |
| Statut OGM | GMO-S1: This CHO cell line contains a CD274 expression cassette supporting receptor-function analyses. This classification applies only within Germany and may differ elsewhere. |
Données biomoléculaires
| Antigènes de surface | PD-L1 (CD274/B7-H1) |
|---|---|
| Récepteurs exprimés | PD-1/CD279 |
Manipulation
| Milieu de culture | For adherent cultures: DMEM:Ham's F12 (1:1), w: 3.1 g/L Glucose, w: 2.5 mM L-Glutamine, w: 15 mM HEPES, w: 0.5 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a) For suspension cultures: CHO Growth Medium A (from InSCREENeX; InSCREENeX catalog number INS-ME-1039) |
|---|---|
| Suppléments | For adherent cultures: Supplement the medium with 5% FBS. Add Geneticin (G418-Sulfat) to achieve a final concentration of 0.5 mg/mL. |
| Réactif de dissociation | For adherent cultures: Trypsin-EDTA |
| Temps de doublement | approx. 14-16 hours |
| Repiquage | For routine adherent cell culture: Aspirate the old culture medium from the adherent cells, and wash them with PBS to remove any remaining medium. After aspirating the PBS, add the appropriate volume of Trypsin/EDTA solution based on the culture vessel size (e.g., 1 ml for a T25 flask, 3 ml for a T75 flask) and incubate at room temperature or 37°C for 5-10 minutes, or until the cells detach. Monitor detachment under a microscope, and gently tap the vessel if necessary to release the cells. Once detached, add complete medium to inactivate the Trypsin/EDTA, gently resuspend the cells, and transfer an aliquot of the cell suspension into a new culture vessel containing fresh medium. Place the vessel in an incubator set to 37°C with 5% CO2, and change the medium every 2-3 days. |
| Rapport de fractionnement | 1 to 5 |
| Densité de semis | 2 to 5 x 104 cells/cm2 |
| Renouvellement des fluides | 2 to 3 times per week |
| Rétablissement après le dégel | After thawing, split the cells at a ratio of 1:2 to 1:3 in T25 flasks and allow the cells to recover from the freezing process and to adhere (for adherent cultures) for at least 24 hours. |
| Milieu de congélation | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Décongélation et culture des cellules |
|
| Atmosphère d'incubation | 37°C, 5% CO2, humidified atmosphere. |
| Conditions d'expédition | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Conditions d'entreposage | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Contrôle de la qualité et analyse moléculaire
| Stérilité | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|